Literature DB >> 29242729

Altered Biodistribution of 99mTc-DPD on Bone Scan After Intravenous Iron Supplement.

Eonwoo Shin1, Minyoung Oh1, Changhwan Sung1, Ki-Hun Kim2, Jin-Sook Ryu1.   

Abstract

We report a case with altered biodistribution of 99mTc-dicarboxypropane diphosphonate (99mTc-DPD) on whole body bone scan after intravenous iron supplement therapy. A 47-year-old male patient who had recently been detected with a hepatic mass suggestive of hepatocellular carcinoma underwent bone scan as staging work-up before surgery. Bone scan images at 3 h after injection of 99mTc-DPD demonstrated unusually increased blood pool activities in the heart, liver, and spleen with usual skeletal uptakes. The patient had been treated for severe anemia from hemorrhoid with two intravenous administration of ferric hydroxide carboxymaltose complex at approximately 22 h and 2 h prior to the 99mTc-DPD injection, which we consider as the most probable cause of altered biodistribution of 99mTc-DPD.

Entities:  

Keywords:  99mTc-DPD; Biodistribution; Bone scan; Iron supplement

Year:  2017        PMID: 29242729      PMCID: PMC5721091          DOI: 10.1007/s13139-017-0486-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

Review 1.  Bone scanning: radionuclidic reaction mechanisms.

Authors:  A G Jones; M D Francis; M A Davis
Journal:  Semin Nucl Med       Date:  1976-01       Impact factor: 4.446

2.  Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex.

Authors:  H H Byun; S G Rodman; K E Chung
Journal:  J Nucl Med       Date:  1976-05       Impact factor: 10.057

Review 3.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

4.  Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.

Authors:  J McRae; P Hambright; P Valk; A J Bearden
Journal:  J Nucl Med       Date:  1976-03       Impact factor: 10.057

5.  Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.

Authors:  J MacDonald
Journal:  J Nucl Med Technol       Date:  2001-03

Review 6.  Bone imaging in metastatic breast cancer.

Authors:  Tsuyoshi Hamaoka; John E Madewell; Donald A Podoloff; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Duration of etidronate effect demonstrated by serial bone scintigraphy.

Authors:  E D Sandler; M T Parisi; R S Hattner
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

8.  Intense concentration of technetium-99m pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease.

Authors:  C L Lutrin; I R McDougall; M L Goris
Journal:  Radiology       Date:  1978-07       Impact factor: 11.105

9.  A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.

Authors:  E K Pauwels; J Blom; J A Camps; J Hermans; A M Rijke
Journal:  Eur J Nucl Med       Date:  1983

10.  The effect of iron on the biodistribution of bone scanning agents in humans.

Authors:  D Choy; I P Murray; R Hoschl
Journal:  Radiology       Date:  1981-07       Impact factor: 11.105

View more
  1 in total

Review 1.  99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.

Authors:  Nobuhiro Tahara; Olivier Lairez; Jin Endo; Atsushi Okada; Mitsuharu Ueda; Tomonori Ishii; Yoshinobu Kitano; Hahn-Ey Lee; Eleonora Russo; Toru Kubo
Journal:  ESC Heart Fail       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.